The Global Nutrigenomics Testing Market Forecast to 2035 released by Emergen Research provides a comprehensive understanding of the industry, covering major market trends, growth opportunities, competitive developments, regional dynamics, and factors expected to influence the market during the forecast period from 2026 to 2035.

The Nutrigenomics Testing Market was valued at USD 1.15 Billion in 2025 and is projected to grow from USD 1.34 Billion in 2026 to USD 4.65 Billion by 2035, registering a CAGR of 14.8% from 2026 to 2035. North America accounted for the largest revenue share of 41.6% in 2025, supported by increasing adoption of genetic testing, growing practitioner interest in personalized nutrition, and the presence of established genomics and nutrigenomics companies. Asia Pacific is expected to register the fastest growth during the forecast period.

The growing adoption of DNA-guided dietary counseling is a major factor supporting the expansion of the Nutrigenomics Testing Market. Healthcare professionals and nutrition practitioners are increasingly incorporating genetic information into personalized dietary recommendations, allowing consumers to receive nutrition guidance based on individual genetic characteristics. The growing interest in personalized healthcare and preventive wellness is further contributing to demand for nutrigenomics testing.

A major factor contributing to the development of the Nutrigenomics Testing Market is the declining cost of sequencing and genotyping technologies. Improvements in genetic testing technologies and laboratory processes are making testing more accessible to consumers, healthcare providers, and research institutions. Lower testing costs are also supporting the development of broader genetic panels and expanding the potential applications of nutrigenomics testing.

The increasing clinical interest in gene-diet interactions is another important factor driving market growth. Researchers and healthcare professionals are studying how genetic variations can influence nutrient metabolism, dietary response, weight management, and chronic disease risk. Continued research in these areas is supporting the development of personalized nutrition approaches and creating new opportunities for nutrigenomics testing providers.

Practitioner networks are also contributing to market expansion. Nutrigenomix has developed a network of more than 12,000 registered dietitians and practitioners across 95 countries, demonstrating the growing role of professional channels in the adoption of DNA-guided nutrition services.

Restructuring within the direct-to-consumer genetic testing industry is also influencing the competitive environment. 23andMe filed for Chapter 11 bankruptcy protection in March 2025, while TTAM Research Institute subsequently completed the acquisition of its Personal Genome Service and Research Services businesses in July 2025. Such developments are contributing to changes in the distribution structure of consumer genetic testing and increasing attention toward genetic-data management and consumer privacy.

The report is designed to provide detailed insights into the key factors shaping the Nutrigenomics Testing Market. It examines market size and forecasts, major growth drivers, restraints, segmentation, regional developments, competitive dynamics, regulatory considerations, and recent industry developments. The study also provides information that can help businesses and stakeholders understand emerging opportunities across different testing types, applications, end users, and geographical markets.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @https://www.emergenresearch.com/request-free-sample/220517

A key feature of the research is its detailed segmentation of the market based on test type, application, end user, and region. By test type, the market is divided into Single Nutrient Testing, Multi-Gene Panel Testing, Whole Genome/Exome-Based Testing, and Others. By application, the market includes Weight Management, Sports Nutrition & Performance, Chronic Disease Risk Management, and Others. By end user, the market is segmented into Direct-to-Consumer, Healthcare Providers & Clinics, Research Institutions, and Others.

The Multi-Gene Panel Testing segment accounted for 46.8% of the global Nutrigenomics Testing Market share in 2025, making it the leading test type segment. Multi-gene panels enable multiple nutrition-related genetic markers to be analyzed through a single testing approach and can support personalized dietary recommendations across different nutritional characteristics.

Meanwhile, the Whole Genome/Exome-Based Testing segment is expected to register a CAGR of 17.2% through 2035, supported by declining sequencing costs, expanding genetic analysis capabilities, and increasing research interest in broader genomic datasets. Whole genome and exome-based approaches can provide extensive genetic information that may support future analysis as new gene-diet relationships are identified.

The growing direct-to-consumer genetic testing ecosystem is also contributing to opportunities within the nutrigenomics industry. The broader sector is discussed in the Direct-to-Consumer Genetic Testing Market report.

Based on application, the Weight Management segment accounted for 38.4% of the global Nutrigenomics Testing Market share in 2025, making it the leading application segment. Increasing consumer interest in personalized approaches to weight management and metabolic health is supporting demand for genetic-based nutritional guidance.

The Chronic Disease Risk Management segment is expected to register a CAGR of 16.4% through 2035, supported by increasing research into the relationship between genetic variations, nutrition, and chronic health conditions. Nutrigenomics testing can provide additional genetic information for personalized nutrition approaches related to metabolic and cardiovascular health.

Based on end user, the Direct-to-Consumer segment accounted for 44.7% of the global Nutrigenomics Testing Market share in 2025. At-home sample collection, online purchasing, and direct access to genetic testing services are supporting consumer adoption of nutrigenomics testing.

Meanwhile, the Healthcare Providers & Clinics segment is expected to register a CAGR of 15.9% through 2035, supported by increasing adoption of DNA-guided dietary counseling among healthcare professionals and nutrition practitioners. Professional interpretation can help consumers understand genetic test results alongside dietary, lifestyle, and other relevant information.

The broader personalized genetic wellness industry is covered in the Predictive Genetic Testing and Consumer Wellness Genomics Market report.

The global Nutrigenomics Testing Market is moderately fragmented, with specialized nutrigenomics companies, genetic testing providers, laboratory companies, and genomics technology providers competing across different market segments. Some of the leading companies operating in the market include 23andMe (TTAM Research Institute), Nutrigenomix Inc., Viome Life Sciences, Inc., Illumina, Inc., Metagenics, Inc., Genova Diagnostics, Inc., 3X4 Genetics, DNAfit, Pathway Genomics Corporation, and Mapmygenome India Limited. Industry participants are focusing on testing innovation, practitioner networks, personalized nutrition solutions, strategic partnerships, and geographic expansion to strengthen their market positions.

Competitive landscape:-

The report provides detailed analysis of the competitive environment and examines the strategies adopted by major companies operating in the Nutrigenomics Testing Market. It covers company developments, testing capabilities, product portfolios, strategic agreements, investments, partnerships, and market expansion activities. The increasing focus on personalized nutrition and integration of genetic testing with professional dietary counseling is also influencing competitive strategies across the industry.

Nutrigenomix has established a significant practitioner network across multiple countries, while Viome Life Sciences has expanded its focus on diagnostics and personalized health solutions. In September 2024, Viome raised USD 25.4 million in Series D funding, supporting the company's diagnostic division, product expansion, and international market development.

23andMe represents another significant development in the competitive landscape. In July 2025, TTAM Research Institute completed the acquisition of 23andMe's Personal Genome Service and Research Services businesses for USD 305 million, following a competitive process that superseded an earlier USD 256 million bid from Regeneron.

The report also provides detailed company-level analysis for major market participants and evaluates their role within the evolving nutrigenomics testing ecosystem.

Another important aspect covered in the report is the regional landscape. The study provides detailed analysis of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, examining market trends, adoption patterns, healthcare infrastructure, genetic testing developments, and growth opportunities across these regions.

North America accounted for 41.6% of the global Nutrigenomics Testing Market revenue share in 2025, making it the leading regional market. The region benefits from established genetic testing infrastructure, growing practitioner adoption, strong consumer awareness, and the presence of major genomics and personalized health companies. The United States led the North American market in 2025.

Europe is projected to grow at a CAGR of 13.6% through 2035, supported by increasing interest in personalized nutrition, genetic testing, and preventive healthcare approaches. Regulatory developments related to genetic data and consumer privacy also remain important considerations for companies operating in the region.

Asia Pacific is projected to register the fastest regional growth at a CAGR of 17.4% through 2035, supported by increasing healthcare investment, expanding genomics capabilities, rising consumer awareness, and growing adoption of personalized healthcare technologies across countries such as China, India, Japan, and South Korea.

Latin America is projected to grow at a CAGR of 12.1% through 2035, supported by increasing access to genetic testing technologies and growing interest in personalized nutrition and preventive healthcare services.

The Middle East & Africa market is expected to register a CAGR of 10.8% through 2035, supported by healthcare modernization, increasing investment in advanced diagnostic technologies, and growing interest in personalized wellness services.

The growth of the Nutrigenomics Testing Market is also supported by increasing interest in personalized dietary recommendations. Consumers and healthcare professionals are increasingly looking beyond generalized nutrition advice and exploring approaches that account for individual genetic characteristics. DNA-guided dietary counseling can provide additional information for nutritional decision-making when combined with appropriate professional interpretation.

At the same time, the industry faces several challenges. One important restraint is the limited randomized-controlled-trial evidence supporting certain single-nutrient-gene dietary claims. Differences in the strength of scientific evidence can affect consumer confidence and practitioner adoption for specific nutrigenomics applications.

Consumer concerns related to genetic privacy represent another challenge. Genetic testing companies collect highly sensitive biological and genetic information, and restructuring within the direct-to-consumer testing industry has increased public attention toward data ownership, storage, privacy, and use.

Regulatory variation across countries also creates challenges for companies operating internationally. In the United States, the FDA regulates genetic tests making medical or disease-related claims, while the FTC has authority over advertising and health-related marketing claims. Genetic data is also subject to privacy requirements such as GINA in the United States and GDPR protections in the European Union.

The cost of specialized sequencing components, reagents, and laboratory technologies can also affect testing providers and laboratories. Changes in supply-chain costs may influence testing prices and operating margins.

The increasing integration of nutrigenomics with personalized healthcare and wellness is creating additional opportunities for market participants. Practitioner-mediated testing can provide consumers with professional interpretation, while direct-to-consumer models can improve accessibility through online purchasing and at-home sample collection.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @https://www.emergenresearch.com/industry-report/nutrigenomics-testing-market

Another important component of the research is its analysis of market segmentation and regional opportunities. The report evaluates developments across different test types, applications, and end users while providing country-level analysis across major markets. This helps businesses identify areas of increasing demand and understand the factors influencing the adoption of nutrigenomics testing.

The study also examines the value chain of the Nutrigenomics Testing Market, extending from sequencing and genotyping technology suppliers to accredited laboratories, healthcare professionals, direct-to-consumer platforms, and end users. Testing providers process genetic samples and generate reports that can be interpreted by practitioners or accessed directly by consumers depending on the distribution model.

Furthermore, the report provides insights into industry developments, regulatory considerations, competitive strategies, technological trends, and future opportunities. The analysis can help existing market participants strengthen their business strategies while providing new entrants with information about market conditions and potential areas of expansion.

Emergen Research also provides customization options, allowing businesses to obtain market information according to their specific requirements. Customized research can help organizations examine particular testing types, applications, end users, countries, competitors, or other areas relevant to their business objectives.

Custom Requirements can be requested for this Report [Customization Available] @https://www.emergenresearch.com/request-for-customization/220517

In conclusion, the Nutrigenomics Testing Market is expected to witness significant expansion through 2035, supported by rising adoption of DNA-guided dietary counseling, declining sequencing and genotyping costs, increasing clinical research into gene-diet interactions, and growing interest in personalized nutrition. The market is projected to grow from USD 1.15 Billion in 2025 to USD 4.65 Billion by 2035 at a CAGR of 14.8%. Although scientific evidence limitations, genetic privacy concerns, regulatory variation, and testing-related costs remain important considerations, continued advances in genetic technologies and increasing integration of personalized nutrition with healthcare are expected to create new opportunities for market participants.

About Emergen Research

Emergen Research is a leading market research and consulting company that provides syndicated reports, customized research solutions, and strategic consulting services. The company focuses on delivering data-driven insights that help businesses understand market trends, assess industry developments, and identify opportunities for sustainable growth.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: [email protected]


Google AdSense Ad (Box)

Comments